How to treat hypertension in patients with peripheral artery disease

Denis L Clement1, Marc L Debuyzere

  • 1Department of the Dean, Ghent University Hospital, Building 3K3, 185, De Pintelaan, B-9000 Ghent, Belgium. denis.clement@UGent.be

Insights

Physicians often underestimate peripheral artery disease (PAD) risk, which hypertension exacerbates. Managing PAD and hypertension requires a focus on triple therapy and controlling total cardiovascular risk for better patient outcomes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Pharmacology

Background:

  • Peripheral artery disease (PAD) risk is frequently underestimated by physicians.
  • Hypertension significantly increases the risk of peripheral artery disease.
  • Early detection of PAD and hypertension is crucial for preventing cardiovascular events.

Purpose of the Study:

  • To review the management of peripheral artery disease as a cardiovascular risk factor.
  • To emphasize the importance of triple therapy in managing PAD.
  • To discuss antihypertensive drug classes and their peripheral circulatory effects.

Main Methods:

  • Literature review on PAD management and hypertension treatment.
  • Analysis of the role of antiplatelet drugs, ACE inhibitors, and statins in triple therapy.
  • Evaluation of antihypertensive medications concerning their impact on peripheral circulation.

Main Results:

  • Triple therapy (antiplatelet drugs, angiotensin-converting enzyme inhibitors, statins) is highlighted for PAD management.
  • Individual antihypertensive drugs show minimal differences in peripheral circulatory effects.
  • Controlling total cardiovascular risk is paramount in patients with PAD and hypertension.

Conclusions:

  • Effective management of PAD necessitates addressing associated risk factors like hypertension.
  • A comprehensive approach to cardiovascular risk reduction is more critical than selecting specific antihypertensive agents.
  • Physicians must improve PAD risk assessment and management strategies.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...